Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
about
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsClinical Specimen-Direct LAMP: A Useful Tool for the Surveillance of blaOXA-23-Positive Carbapenem-Resistant Acinetobacter baumanniiClonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospitalAnticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsMathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.Therapy of Infections due to Carbapenem-Resistant Gram-Negative PathogensFulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysisMolecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USAImpact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates.Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity.Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis.Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumanniiMulticenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms.Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China.Antibiotic resistance and phylogenetic characterization of Acinetobacter baumannii strains isolated from commercial raw meat in Switzerland.Acquisition of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: just a question of time?The deadly impact of extreme drug resistance in Acinetobacter baumannii.Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time?Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections.Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study.Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials.Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia.Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia.Bacterial zincophore [S,S]-ethylenediamine-N,N'-disuccinic acid is an effective inhibitor of MBLs.Herbicide ingredients change Salmonella enterica sv. Typhimurium and Escherichia coli antibiotic responses.Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: A prospective cohort study in 937 Germany ICUs (2006-2015).Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea.Preventing sepsis in healthcare - 200 years after the birth of Ignaz Semmelweis.Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality.Characteristics and Outcomes of Acinetobacter baumannii Infections in Patients with HIV: A Matched Case-Control Study
P2860
Q26991886-DE9DDE33-422A-493D-BBC1-CFAA8135FAB0Q27015109-1BD2EC9E-59BC-48E3-872F-46EC7BFD8F56Q28546812-6556A67C-80CB-4B6E-B050-DB5A7A5184F9Q33610935-A1502DAF-558E-4DAC-B758-39A0661F379DQ33732524-409B6DF5-A0B8-47F3-80DA-6483C66C66CDQ34057420-6B29EED4-08C1-408D-81D2-CD257EEB6DBEQ34303970-C3C45926-16FA-4A9C-9FD0-D4B13905A663Q35235590-D20F5AE7-E7F1-45D1-B2B1-F459447581EFQ35673458-9F7AF027-3FDF-4294-AFD4-63F8970F6A3BQ36008636-308687C2-2CF0-4C3B-9C71-ADC3384934A1Q36298237-CFF2E5A3-F3BC-4296-9F9C-0616162AF230Q36928268-A7480120-1C8C-4F98-B19B-BB535BF89BB7Q37438110-C815CCC7-6356-43FD-A1EE-1BB785A37F07Q37735085-D6CBA2D5-5D90-4ABB-BDFC-0A8CE7560F76Q39063044-88413CCB-82DD-4BD5-BEC0-654D6B6A4230Q39167693-C4527E5E-3A83-4211-9FE0-061E9A67BFF6Q39391864-D23CC8DB-1813-4723-AB49-EFDFAEEB1AC0Q39882067-4022BB8C-6113-43E6-9E53-7B5ABA58A4B8Q40226218-082BC5BA-9DF3-4890-A639-8FD8FD93F026Q40234980-CF05751A-DD7E-44E1-8FFC-96D8D86AB26CQ40540026-ED4E870E-AA20-46CD-AD3F-4CE6D2673555Q40964002-764E3F74-F593-4EB4-840C-F7E6D74039C4Q41680011-29D5FB11-3C4C-4443-BDF0-96F0F5A2D391Q42370350-F6622E7D-F9FB-4333-ACF3-7A4B969BEFA5Q42575612-B90C68D5-8824-4E76-869A-D633379DBB20Q43202091-68049F21-4BD8-495F-9A6C-CCDB00CF6C79Q45796678-72167362-16B0-4E85-901C-CBC80BE08B64Q46293606-4FB09BF7-5781-4E5D-B6B1-42267EB2DEEFQ47129511-902234A8-562C-4941-B89C-4C3A8BFFF74FQ47214206-9A6E1AE2-6DC8-4D0F-9077-AFBD6B80C277Q47661746-CD444693-68DD-4D9F-A18E-D4D416A68257Q49526113-DA982CBF-9777-4CCB-B135-A2F650F6BDDFQ49549528-F0562323-B683-48DB-B55D-1B8CB1C5C7F6Q49933499-9609D86D-92CE-48DE-9970-AAE821734193Q50082670-5EA257F3-BE74-40E7-98B0-53BB2A7CB7E0Q52808222-570C8D39-A68F-4814-8348-ACDC876B7E14Q53704499-478AF19C-4485-4EE8-B67C-E6E9557C1152Q54217442-13D1E8EA-8763-4D82-8A44-46FF21B1A540Q55378575-4B135101-06BD-4574-BE9F-D8A7EEE462CEQ57799888-94503D4A-3517-4589-A7EA-B25F6C5DB3F6
P2860
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Carbapenem resistance and mort ...... matic review and meta-analysis
@ast
Carbapenem resistance and mort ...... matic review and meta-analysis
@en
Carbapenem resistance and mort ...... matic review and meta-analysis
@nl
type
label
Carbapenem resistance and mort ...... matic review and meta-analysis
@ast
Carbapenem resistance and mort ...... matic review and meta-analysis
@en
Carbapenem resistance and mort ...... matic review and meta-analysis
@nl
prefLabel
Carbapenem resistance and mort ...... matic review and meta-analysis
@ast
Carbapenem resistance and mort ...... matic review and meta-analysis
@en
Carbapenem resistance and mort ...... matic review and meta-analysis
@nl
P2093
P31
P921
P3181
P356
P1476
Carbapenem resistance and mort ...... matic review and meta-analysis
@en
P2093
C. Castañeda
E. Quevedo
E.V. Lemos
F.P. de la Hoz
T.R. Einarson
W.F. McGhan
P304
P3181
P356
10.1111/1469-0691.12363
P407
P577
2014-05-01T00:00:00Z